about
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple scle...
Read More
0.63
-0.02
(-3.08%)
313.2K
XNAS Volume
XNAS 11 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
FibroBiologics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..